Get In Touch with AvantGuard
Please tell us a little bit about yourself and why you'd like to get connected. AvantGuard + SOSV will follow up with you via email.
AvantGuard is a venture backed, Cornell University spin-off, IndieBio alum with grant funding from the NIH and NSF, among others, run by an experienced entrepreneur. Our first target is multi-drug resistant Candida auris. Once on your skin, there is no current way to eliminate C. auris and you have a 20% chance of getting an infection that carries a 40% mortality rate in 30 days. We can eliminate C. auris, and are planning a clinical trial with assistance from the Mycoses Study Group – the leaders in the field of antifungal medicine in the US. From that success, we will expand to the $4Bn billion fungal skin infection market and the $5Bn healthcare antiseptic market and eventually create a new standard of care, >$50Bn worth of markets, for the post-antibiotic world since antibiotics are losing their effectiveness.
15 minutes after cleaning a surface with bleach, the bleach disappears, and a surface can be recolonized by nearby microorganisms. Now ask yourself: how often are surfaces cleaned with disinfectants?
We're looking for a world where your disinfectants last longer than your deodorants.
Please tell us a little bit about yourself and why you'd like to get connected. AvantGuard + SOSV will follow up with you via email.
No Offer, Solicitation, Advice, or Recommendation
Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.